The vaccination presentation was introduced in 2015 after a sharp rise in a particularly virulent hint of meningococcal W (Men W) disease, which can lead to death.
Figures show a year-on-year distend in cases of Men W across all age groups — from 22 cases in 2009/10 to 210 occasions in 2015/16.
The total number of related deaths has also risen, with one in eight people with the Men W illness dying from the infection.
New students, especially freshers, are at a higher chance of meningococcal disease. They mix closely with large numbers of new people, some of whom compel unknowingly be carrying the bacteria, without any signs or symptoms, enabling it to spread.
Meningococcal disease can develop suddenly, usually as meningitis or septicaemia.
Betimes symptoms include severe diarrhoea and vomiting, headaches, muscle vexation, fever, and cold hands and feet.
It can kill, or leave people with life-changing disabilities or robustness problems, like hearing loss, brain damage or the loss of a limb.
Primary year students remain at significantly greater risk than most under age people from this deadly disease.
What are the symptoms?
The MenACWY vaccination prearrange was introduced in 2015 in response to a large increase in infections caused by a incomparably aggressive strain of group W meningococcal bacteria (Men W).
The disease can develop instantly and progress rapidly. Early symptoms include headache, vomiting, muscle travail, fever, and cold hands and feet.
Students should be alert to the join ups and symptoms and should not wait for a rash to develop before seeking medical distinction urgently. Students are also encouraged to look out for their friends, exceptionally if they go to their room unwell.
The vaccine not only protects those who are vaccinated, but also takes control the spread of the disease amongst the wider population. This is the instant year the vaccine is being offered to this age group.
Vinny Smith, Chief Principal of Meningitis Research Foundation (MRF) said: “We welcome this new updated rule from PHE which will help higher education institutions cheer up awareness of the MenACWY vaccine.
«Research funded by MRF helped identify that the MenW tax of meningitis was particularly deadly and on the increase, yet uptake of the lifesaving vaccine to guard against it is still too low.
«We will continue to encourage students to get their vaccine and to differentiate the symptoms of this deadly disease, but universities and parents too can play a key responsibility in making sure that eligible students get their free vaccine.”